- CA$37.70m
- CA$150.23m
- $47.51m
- 14
- 83
- 53
- 49
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 15 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 121 | 75.9 | 65.2 | 61.8 | 47.5 |
Cost of Revenue | |||||
Gross Profit | 81.5 | 56.3 | 50.4 | 44.6 | 30.6 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 108 | 83.3 | 50.3 | 50.2 | 48.8 |
Operating Profit | 13 | -7.4 | 15 | 11.6 | -1.26 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -2.11 | -35.2 | 22 | 2.88 | -10.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | -13.8 | -41.5 | 18.5 | 0.709 | -12.3 |
Net Income Before Extraordinary Items | |||||
Net Income | -13.8 | -41.5 | 18.5 | 0.709 | -12.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -13.8 | -41.5 | 18.5 | 0.709 | -12.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -2.82 | -7.79 | 3.11 | 0.115 | -1.98 |
Dividends per Share |